nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibody-based therapies for the treatment of brain metastases from HER2-positive breast cancer: time to rethink the importance of the BBB?
|
Askoxylakis, Vasileios |
|
2017 |
165 |
2 |
p. 467-468 |
artikel |
2 |
Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study
|
Vernieri, Claudio |
|
2017 |
165 |
2 |
p. 365-373 |
artikel |
3 |
A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104)
|
Goldstein, Lori J. |
|
2017 |
165 |
2 |
p. 375-382 |
artikel |
4 |
Breast cancer electron intraoperative radiotherapy: assessment of preoperative selection factors from a retrospective analysis of 758 patients and review of literature
|
Takanen, S. |
|
2017 |
165 |
2 |
p. 261-271 |
artikel |
5 |
Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers
|
Lin, Cheryl |
|
2017 |
165 |
2 |
p. 247-260 |
artikel |
6 |
COX2 induction: a mechanism of endocrine breast cancer resistance?
|
Clark, Brandi L. |
|
2017 |
165 |
2 |
p. 383-389 |
artikel |
7 |
Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer
|
Goncalves, Rodrigo |
|
2017 |
165 |
2 |
p. 355-364 |
artikel |
8 |
Erratum to: Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial
|
González-Rivera, Milagros |
|
2017 |
165 |
2 |
p. 471 |
artikel |
9 |
Incidence and treatments of DCIS in octogenarians: grade matters
|
Ward, Erin P. |
|
2017 |
165 |
2 |
p. 403-409 |
artikel |
10 |
Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes
|
Yaghjyan, Lusine |
|
2017 |
165 |
2 |
p. 421-431 |
artikel |
11 |
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients
|
Palmieri, Carlo |
|
2017 |
165 |
2 |
p. 343-353 |
artikel |
12 |
Is there a role for sentinel node biopsy in the pre-operative ultrasound positive axilla?
|
Ahmed, M. |
|
2017 |
165 |
2 |
p. 225-228 |
artikel |
13 |
Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer
|
Houssami, Nehmat |
|
2017 |
165 |
2 |
p. 273-283 |
artikel |
14 |
Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens
|
Tan, Xi |
|
2017 |
165 |
2 |
p. 455-465 |
artikel |
15 |
Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review
|
Brot, Marina De |
|
2017 |
165 |
2 |
p. 411-420 |
artikel |
16 |
Predictors of distress in female breast cancer survivors: a systematic review
|
Syrowatka, Ania |
|
2017 |
165 |
2 |
p. 229-245 |
artikel |
17 |
Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment
|
Liede, Alexander |
|
2017 |
165 |
2 |
p. 433-444 |
artikel |
18 |
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial
|
Cortés, Javier |
|
2017 |
165 |
2 |
p. 329-341 |
artikel |
19 |
Reassessing risk models for atypical hyperplasia: age may not matter
|
Mazzola, Emanuele |
|
2017 |
165 |
2 |
p. 285-291 |
artikel |
20 |
Response Letter
|
Phillips, Gail Lewis |
|
2017 |
165 |
2 |
p. 469-470 |
artikel |
21 |
Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer
|
Heimes, A.-S. |
|
2017 |
165 |
2 |
p. 293-300 |
artikel |
22 |
Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy
|
Yoon, Tae In |
|
2017 |
165 |
2 |
p. 311-320 |
artikel |
23 |
The efficacy of lymphaticovenular anastomosis in breast cancer-related lymphedema
|
Winters, H. |
|
2017 |
165 |
2 |
p. 321-327 |
artikel |
24 |
The financial impact and drivers of hospital charges in contralateral prophylactic mastectomy and reconstruction: a Nationwide Inpatient Sample hospital analysis
|
Bucknor, Alexandra |
|
2017 |
165 |
2 |
p. 301-310 |
artikel |
25 |
The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients
|
Sopik, Victoria |
|
2017 |
165 |
2 |
p. 391-402 |
artikel |
26 |
Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis
|
Diwanji, Tejan P. |
|
2017 |
165 |
2 |
p. 445-453 |
artikel |